Transcriptional Mechanisms for Redox Stress in the Cardiovascular System

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "RNA".

Deadline for manuscript submissions: closed (20 December 2022) | Viewed by 2489

Special Issue Editor


E-Mail Website
Guest Editor
Departments of Pathology & Medicine, University of Alabama at Birmngham, Birmingham, AL 35294, USA
Interests: redox biology; cardiac biology; cardiac hypertrophy; heart failure; Nrf2 signaling; cardiac ageing; cardiomyopathy; proteotoxicity and proteostasis; arrhythmia; atrial remodeling

Special Issue Information

Dear Colleagues,

We have come a long way in understanding the role of redox processes in the cardiovascular system under basal and stress conditions. In particular, changes in the redox state toward either of the arms (i.e., oxidative or reductive) influences cardiac development, metabolism, physiology, and pathology, including atherosclerosis, cardiomyopathy, ischemic/reperfusion injury, and heart failure. The interplay between oxidants (ROS/RNS) and reductants (antioxidants) controls various physiological pathways and stress responses. However, the relationship has so far proven to be more complex and intricately regulated. For instance, the disappointing clinical expectations of antioxidant treatments are evidence of this nature as we begin to understand the balance between the two. In part, this might be due to the fact that while reductive or oxidative stress seems to be detrimental, a moderate pro-oxidative condition exerting a eustress is desired by myocytes for acting as electron donors for cellular signaling and function. It is imperative that we apply newer concepts and ideas to unravel this gap in knowledge. In this juncture, understanding the global changes in myocardial transcriptome and associated effects in the heart at basal and disease settings will facilitate the scientific community, pharmaceutical industry, healthcare professionals, as well as the public with up-to-date knowledge to improve cardiac health and outcomes.

This brings us to the message of this Special Issue that emphasizes discovering novel mechanisms in irremediable heart diseases involving excess/insufficient oxidants (i.e., ROS/RNS) or reductants (i.e., antioxidants) at the level of transcriptional regulation and gene expression. Our aim here is to better understand pathophysiology to design preventive and therapeutic strategies through enhanced knowledge on gene regulation/transcription. Therefore, we provide recent insights into the field of redox biology in the context of heart diseases, including cardiac hypertrophy, coronary artery disease, heart failure, arrhythmia, hypertension, and stroke. We hope this will inspire further lines of research.

Dr. Rajasekaran Namakkal-Soorappan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gene regulation
  • Nrf2-antioxidant signaling
  • transcription factors
  • myocardial transcriptome
  • redox transcriptome
  • epigenetic regulation
  • redox stress

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 3531 KiB  
Article
Transgenic Expression of Nrf2 Induces a Pro-Reductive Stress and Adaptive Cardiac Remodeling in the Mouse
by Arun Jyothidasan, Sini Sunny, Saravanakumar Murugesan, Justin M. Quiles, Anil Kumar Challa, Brian Dalley, Senthil Kumar Cinghu, Vivek Nanda and Namakkal-Soorappan Rajasekaran
Genes 2022, 13(9), 1514; https://doi.org/10.3390/genes13091514 - 24 Aug 2022
Cited by 5 | Viewed by 2042
Abstract
Nuclear factor, erythroid 2 like 2 (Nfe2l2 or Nrf2), is a transcription factor that protects cells by maintaining a homeostatic redox state during stress. The constitutive expression of Nrf2 (CaNrf2-TG) was previously shown to be pathological to the heart over time. We tested [...] Read more.
Nuclear factor, erythroid 2 like 2 (Nfe2l2 or Nrf2), is a transcription factor that protects cells by maintaining a homeostatic redox state during stress. The constitutive expression of Nrf2 (CaNrf2-TG) was previously shown to be pathological to the heart over time. We tested a hypothesis that the cardiac-specific expression of full length Nrf2 (mNrf2-TG) would moderately increase the basal antioxidant defense, triggering a pro-reductive environment leading to adaptive cardiac remodeling. Transgenic and non-transgenic (NTG) mice at 7–8 months of age were used to analyze the myocardial transcriptome, structure, and function. Next generation sequencing (NGS) for RNA profiling and qPCR-based validation of the NGS data, myocardial redox levels, and imaging (echocardiography) were performed. Transcriptomic analysis revealed that out of 14,665 identified mRNAs, 680 were differently expressed (DEG) in TG hearts. Of 680 DEGs, 429 were upregulated and 251 were downregulated significantly (FC > 2.0, p < 0.05). Gene set enrichment analysis revealed that the top altered pathways were (a) Nrf2 signaling, (b) glutathione metabolism and (c) ROS scavenging. A comparative analysis of the glutathione redox state in the hearts demonstrated significant differences between pro-reductive vs. hyper-reductive conditions (233 ± 36.7 and 380 ± 68.7 vs. 139 ± 8.6 µM/mg protein in mNrf2-TG and CaNrf2-TG vs. NTG). Genes involved in fetal development, hypertrophy, cytoskeletal rearrangement, histone deacetylases (HDACs), and GATA transcription factors were moderately increased in mNrf2-TG compared to CaNrf2-TG. Non-invasive echocardiography analysis revealed an increase in systolic function (ejection fraction) in mNrf2-TG, suggesting an adaptation, as opposed to pathological remodeling in CaNrf2-TG mice experiencing a hyper-reductive stress, leading to reduced survival (40% at 60 weeks). The effects of excess Nrf2-driven antioxidant transcriptome revealed a pro-reductive condition in the myocardium leading to an adaptive cardiac remodeling. While pre-conditioning the myocardial redox with excess antioxidants (i.e., pro-reductive state) could be beneficial against oxidative stress, a chronic pro-reductive environment in the myocardium might transition the adaptation to pathological remodeling. Full article
Show Figures

Figure 1

Back to TopTop